Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia

1 clinical trials · Condition

Record	Firm	Date
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma (NCT01209130)	Genentech, Inc.	2010-10-01

Every clearance here is in the API, with alerts when new ones post.